Cyclosporin A (CycA) is a peptide secondary metabolite derived from fungi that plays a crucial role in transplantation surgery. Cyclic traveling wave ion mobility mass spectrometry (IM-MS) revealed an N → O peptidyl shift in singly protonated CycA to isocyclosporin A (isoA), whereas no such isomerization was observed for doubly protonated and sodiated molecules. CycA and isoA were able to be separated by considering doubly protonated precursors using a specific ion fragment. In parallel, sodium ion stabilization facilitated the simultaneous separation and quantitation of singly charged cyclosporin isomers with the limit of detection and coefficient of determination of 1.3% and 0.9908 for CycA in isoA and 1.0% and 0.9830 for isoA in CycA, respectively. Finally, 1H-13C gHSQC NMR experiments permitted parallel recording of up to 11 cyclosporin conformers. The ratios were determined by integrating the volume of cross-peaks of the upfield resonating hydrogen in the diastereotopic methylene group of sarcosine-3.

Department of Analytical Chemistry Faculty of Science Palacký University 17 listopadu 12 Olomouc 771 46 Czech Republic

Institute of Microbiology of the Czech Academy of Sciences Vídeňská 1083 Prague 142 00 Czech Republic

See more in PubMed

Dreyfuss M.; Harri E.; Hofmann H.; Kobel H.; Pache W.; Tscherter H. Cyclosporin A and C. Eur. J. Appl. Microbiol. 1976, 3, 125–133. 10.1007/BF00928431. DOI

Survase S. A.; Kagliwal L. D.; Annapure U. S.; Singhal R. S. Cyclosporin A-a review on fermentative production, downstream processing and pharmacological applications. Biotechnol. Adv. 2011, 29 (4), 418–435. 10.1016/j.biotechadv.2011.03.004. PubMed DOI

Nielsen D. S.; Shepherd N. E.; Xu W.; Lucke A. J.; Stoermer M. J.; Fairlie D. P. Orally absorbed cyclic peptides. Chem. Rev. 2017, 117 (12), 8094–8128. 10.1021/acs.chemrev.6b00838. PubMed DOI

Lipinski C. A.; Lombardo F.; Dominy B. W.; Feeney P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 2001, 46 (1–3), 3–26. 10.1016/S0169-409X(00)00129-0. PubMed DOI

Wang C. K.; Swedberg J. E.; Harvey P. J.; Kaas Q.; Craik D. J. Conformational flexibility is a determinant of permeability for cyclosporin. J. Phys. Chem. B 2018, 122 (8), 2261–2276. 10.1021/acs.jpcb.7b12419. PubMed DOI

Marelli U. K.; Ovadia O.; Frank A. O.; Chatterjee J.; Gilon C.; Hoffman A.; Kessler H. cis-peptide bonds: A key for intestinal permeability of peptides?. Chem.—Eur. J. 2015, 21 (43), 15148–15152. 10.1002/chem.201501600. PubMed DOI

Corbett K. M.; Ford L.; Warren D. B.; Pouton C. W.; Chalmers D. K. Cyclosporin structure and permeability: From A to Z and beyond. J. Med. Chem. 2021, 64 (18), 13131–13151. 10.1021/acs.jmedchem.1c00580. PubMed DOI

Ono S.; Naylor M. R.; Townsend C. E.; Okumura C.; Okada O.; Lee H.-W.; Lokey R. S. Cyclosporin A: Conformational Complexity and Chameleonicity. J. Chem. Inf. Model. 2021, 61 (11), 5601–5613. 10.1021/acs.jcim.1c00771. PubMed DOI PMC

Carver J. A.; Rees N. H.; Turner D. L.; Senior S. J.; Chowdhry B. Z. NMR studies of the Na+, Mg2+ and Ca2+ complexes of cyclosporin A. J. Chem. Soc., Chem. Commun. 1992, (22), 1682.10.1039/c39920001682. DOI

Bernardi F.; Gaggelli E.; Molteni E.; Porciatti E.; Valensin D.; Valensin G. 1H and 13C-NMR and molecular dynamics studies of cyclosporin a interacting with magnesium(II) or cerium(III) in acetonitrile. Conformational changes and cis-trans conversion of peptide bonds. Biophys. J. 2006, 90 (4), 1350–61. 10.1529/biophysj.105.074245. PubMed DOI PMC

Kock M.; Kessler H.; Seebach D.; Thaler A. Novel Backbone Conformation of Cyclosporin A: The Complex with Lithium Chloride. J. Am. Chem. Soc. 1992, 114, 2676–2686. 10.1021/ja00033a048. DOI

Ko S. Y.; Dalvit C. Conformation of cyclosporin A in polar solvents. Int. J. Pept. Protein Res. 1992, 40, 380–382. 10.1111/j.1399-3011.1992.tb00314.x. PubMed DOI

Shaw R. A.; Mantsch H. H.; Chowdhry B. Z. Solvent influence on the conformation of cyclosporin. An FT-IR study. Can. J. Chem. 1993, 71 (9), 1334–1339. 10.1139/v93-172. DOI

Oliyai R.; Stella V. J. Kinetics and mechanism of isomerization of cyclosporin A. Pharm. Res. 1992, 9 (5), 617–622. 10.1023/A:1015841824760. PubMed DOI

Oliyai R.; Siahaan T. J.; Stella V. J. The importance of structural factors on the rate and the extent of N,O-acyl migration in cyclic and linear peptides. Pharm. Res. 1995, 12 (3), 323–328. 10.1023/A:1016231913858. PubMed DOI

Bonifacio F. N.; Giocanti M.; Reynier J. P.; Lacarelle B.; Nicolay A. Development and validation of HPLC method for the determination of Cyclosporin A and its impurities in Neoral capsules and its generic versions. J. Pharm. Biomed. Anal. 2009, 49 (2), 540–546. 10.1016/j.jpba.2008.11.027. PubMed DOI

Jegorov A.; Havlicek V. Spontaneous N --> O acyl shift in the [M + H](+) ions of [MeBmt1]-cyclosporins in an ion trap. J. Mass Spectrom. 2001, 36 (6), 633–640. 10.1002/jms.163. PubMed DOI

Baranova A. A.; Chistov A. A.; Shuvalov M. V.; Tyurin A. P.; Biryukov M. V.; Ivanov I. A.; Sadykova V. S.; Kurakov A. V.; Sergeeva A. I.; Korshun V. A.; Alferova V. A. Identification of isocyclosporins by collision-induced dissociation of doubly protonated species. Talanta 2021, 225, 12193010.1016/j.talanta.2020.121930. PubMed DOI

Cirigliano A. M.; Cabrera G. M. Differentiation of cyclosporin A from isocyclosporin A by liquid chromatography/electrospray ionization mass spectrometry with post-column addition of divalent metal salt. Rapid Commun. Mass Spectrom. 2014, 28 (5), 465–70. 10.1002/rcm.6805. PubMed DOI

Goodwin C. R.; Fenn L. S.; Derewacz D. K.; Bachmann B. O.; McLean J. A. Structural mass spectrometry: rapid methods for separation and analysis of peptide natural products. J. Nat. Prod. 2012, 75 (1), 48–53. 10.1021/np200457r. PubMed DOI PMC

Lam K. H. B.; Le Blanc J. C. Y.; Campbell J. L. Separating Isomers, Conformers, and Analogues of Cyclosporin using Differential Mobility Spectroscopy, Mass Spectrometry, and Hydrogen-Deuterium Exchange. Anal. Chem. 2020, 92 (16), 11053–11061. 10.1021/acs.analchem.0c00191. PubMed DOI

Gray A. L. H.; Steren C. A.; Haynes I. W.; Bermejo G. A.; Favretto F.; Zweckstetter M.; Do T. D. Structural flexibility of cyclosporine A is mediated by amide cis-trans isomerization and the chameleonic roles of calcium. J. Phys. Chem. B 2021, 125 (5), 1378–1391. 10.1021/acs.jpcb.0c11152. PubMed DOI

Hyung S. J.; Feng X.; Che Y.; Stroh J. G.; Shapiro M. Detection of conformation types of cyclosporin retaining intramolecular hydrogen bonds by mass spectrometry. Anal. Bioanal. Chem. 2014, 406, 5785–5794. 10.1007/s00216-014-8023-1. PubMed DOI

Tian Z.; Kass S. R. Does electrospray ionization produce gas-phase or liquid-phase structures?. J. Am. Chem. Soc. 2008, 130, 10842–10843. 10.1021/ja802088u. PubMed DOI

Schroder D.; Budesinsky M.; Roithova J. Deprotonation of p-hydroxybenzoic acid: does electrospray ionization sample solution or gas-phase structures?. J. Am. Chem. Soc. 2012, 134 (38), 15897–15905. 10.1021/ja3060589. PubMed DOI

Haynes I. W.; Wu G.; Haque M. A.; Li H.; Do T. D. Conformational preference of macrocycles investigated by ion-mobility mass spectrometry and distance geometry modeling. Anal. Chem. 2019, 91 (21), 13439–13447. 10.1021/acs.analchem.9b02100. PubMed DOI

Novak J.; Lemr K.; Schug K. A.; Havlicek V. CycloBranch: De novo sequencing of nonribosomal peptides from accurate product ion mass spectra. J. Am. Soc. Mass. Spectrom. 2015, 26 (10), 1780–1786. 10.1007/s13361-015-1211-1. PubMed DOI

Havlíček V.; Jegorov A.; Sedmera P.; Ryska M. Sequencing of cyclosporins by fast atom bombardment and linked-scan mass spectrometry. Org. Mass Spectrom. 1993, 28 (12), 1440–1447. 10.1002/oms.1210281214. DOI

Paizs B.; Suhai S. Fragmentation pathways of protonated peptides. Mass Spectrom. Rev. 2005, 24 (4), 508–48. 10.1002/mas.20024. PubMed DOI

Williams S. M.; Brodbelt J. S. MS(n) characterization of protonated cyclic peptides and metal complexes. J. Am. Soc. Mass. Spectrom. 2004, 15 (7), 1039–54. 10.1016/j.jasms.2004.03.015. PubMed DOI